Published in
American Association for Cancer Research, Cancer Discovery, 12(12), p. 2747-2753, 2022
DOI: 10.1158/2159-8290.cd-22-1154
Links
Tools
Precision Oncology: 2022 in Review
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Summary:This article presents a review of the major advances and future implications in precision oncology accomplished in 2022 and centers on three primary pillars: advances in (i) rational drug design, (ii) study design, and (iii) novel biomarkers.